Change and significance of nuclear factor-κB in adriamycin induced cardiomyopathy in rats

Chinese Medical Journal

Volumn 118, Issue 2, 2005, Pages 111-115

  Li, Hong Li ^a   Liu, Bin ^a   Zhou, Ling Wang ^a   Yu, Wei Han ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Adriamycin; Myocardium; Nuclear factor B; Pyrrolidine dithiocarbamate

Indexed keywords

DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN P50; PROTEIN P53; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CARDIOMYOPATHY; CELL NUCLEUS; CONTROLLED STUDY; EPICARDIUM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART MUSCLE INJURY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN LOCALIZATION; RANDOMIZATION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARDIOMYOPATHIES; DOXORUBICIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, P53; MALE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN PRECURSORS; RATS; RATS, WISTAR;

EID: 13644261776     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986;46:705-716.
2. Finco TS, Baldwin AS. Mechanistic aspects of NF-kB regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995;3:263-272.
3. Barnes PJ, Karin M. Nuclear factor-kB-A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;366:1066-1071.
4. Herman EH, Ferrans VJ, Myers CE, et al. Comparison of the effectiveness of (+/-) -1 ,2bis (3. 5-dioxopiperazinyl-1-yl) propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardio toxicity in beagles. Cancer Res 1985;45:276-281.
5. Kopp EB, Ghosh S. NF-k B and rel proteins in innate immunity. Adv Immunol 1995;58:1-27.
6. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-k B. Annu Rev Cell Biol 1994;10:405-455.
7. Baeuerle PA, Baltimore D. NF-k B: ten years after. Cell 1996;87:13-20.
8. XU Jun, XIE Jun, BAO Minsheng, etal. NF-kappaB/I-kappaB pathway during ischemia reperfusion injury of rat liver. Chin Med J 2003;116:1146-1149.
9. Pahl HL. Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 1999;18:6853-6861.
10. Martin RD, Hoeth M, Warbinsk RH, et al. The Transcription factor NF-κB and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 2000;20:c83-c88.
11. Boland, MP, Foster, SJ and O'Neill, LAJ. Daunorubicin activates NF-kB and induces kB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. Biol Chem 1997;272:12952-12960.
12. Aoki M, Nata T, Morishita R, et al. Endothelial apoptosis induced by oxidative stress through activation of NF-kB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001;38:48-55.
13. Lauzurica P, Martinez S, Marazuela M, et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by L PS o r TN F-alpha. Eur J Immunol, 1999;29:1890-1900.
14. Christiane Viedt, Judith Vogel, Thomas Athanasiou, et al. Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-kB and Activator Protein-1. Arterioscler Thromb Vasc Biol 2002;22:914-920.